Clinical Trial Update: Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a prothrombin complex concentrate for rapid reversal of vitamin K antagonist–induced coagulopathy in Japanese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulopathy
• Major Bleeding

Drugs mentioned

• Prothrombin Complex Concentrate (prothrombin complex concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Acute Major Bleeding, Reversal of Coagulopathy | Phase 3 | Status: COMPLETED